Overview

A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term efficacy and safety of galantamine in patients with Alzheimer's disease.
Phase:
Phase 3
Details
Lead Sponsor:
Janssen-Cilag S.p.A.
Treatments:
Galantamine